POLO is a Phase III randomised, double-blinded, placebo-controlled, multicentre trial involving 154 patients with gBRCAm metastatic pancreatic cancer whose disease had not progressed on 1st-line platinum-based chemotherapy. The
The post Myriad reveals study results on BRACAnalysis CDx companion diagnostic test appeared first on NS Medical Devices.